| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.32 | 7e-20 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-18 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-18 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.32 | 8e-17 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-16 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-16 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-16 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-15 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-14 |